// App-Quantinova.ai

: Whole-exome sequencing of single circulating tumor cells is a useful tool for studying the intrapatient genetic heterogeneity in metastatic prostate cancer.

Researchers

Presenter

  • Vincent Faugeroux

Principal Investigators

  • Celine Lefebvre

  • Emma Pailler

  • Valerie Pierron

  • Fanny Billiot

  • Charles Marcaillou

  • Sebastien Tourlet

  • Philippe Vielh

  • Semih Dogan

  • Philippe Rameau

  • Maud Ngocamus

  • Christophe Massard

  • Jean-Charles Soria

  • Karim Fizazi

  • Arjan Tibbe

  • Sylvia Julien

  • Yohann Loriot

  • Francoise Farace

Medical Centers

  • Gustave Roussy Cancer Campus, Villejuif, France

  • INSERM U981, Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, France

  • Inserm U981 Identification of Molecular Predictors and New Targets for Cancer Treatment, Villejuif, France

  • Ipsen, Cedex, France

  • Gustave Roussy, Universite Paris-Saclay, Villejuif, France

  • IntegraGen, Evry, France

  • Ipsen, Les Ulis, France

  • Department of Medicine. Gustave Roussy Cancer Campus, Universite Paris-Saclay, Villejuif, France

  • Institut Gustave Roussy Cancer Centre, Villejuif, France

  • Gustave Roussy Cancer Campus and Paris-Sud University, Villejuif, France

  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France

  • Vycap, Enschede, Netherlands

  • Department of Cancer Medicine, Institut Gustave Roussy, Paris-Sud University, Villejuif, France

  • University of Paris Sud, Universite Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicetre, France

Locations

  • France

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Enzalutamide

  • CB-7598

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved